doi: 10.3389/fendo.2021.645617 Received 23 December 2020 Accepted 08 March 2021 Published 25 June 2021 Volume 12 - 2021 Edited by Gaetano Santulli, Columbia University, United States Reviewed by Bo Ahrn, Lund University, Sweden
Like all treatments, Semaglutide GLP-1 can cause side effects such as constipation, diarrhea, and nausea, which usually subside as the body adjusts
Rybelsus is also associated with gastrointestinal adverse effects, particularly during the initial weeks of treatment
Cognitive Support and Alzheimer's Prevention Emerging research highlights GLP-1s potential in supporting brain health
Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome
others find a weekly injection far easier to integrate into their routine than remembering a pill every single morning